Posted November 30, 2016
The FDA’s attack on independent lab testing appears to have been beaten back. In a recent announcement, the US Food and Drug Administration (FDA) said that it will back off of its plans to put new rules in place for laboratory-developed tests (LDTs), rules that represented an attempted regulatory takeover of the industry. Read more.